265 related articles for article (PubMed ID: 15011166)
1. [Tourette syndrome: an analysis of its comorbidity and specific treatment].
Castellanos FX; Acosta MT
Rev Neurol; 2004 Feb; 38 Suppl 1():S124-30. PubMed ID: 15011166
[TBL] [Abstract][Full Text] [Related]
2. Guanfacine treatment of comorbid attention-deficit hyperactivity disorder and Tourette's syndrome: preliminary clinical experience.
Chappell PB; Riddle MA; Scahill L; Lynch KA; Schultz R; Arnsten A; Leckman JF; Cohen DJ
J Am Acad Child Adolesc Psychiatry; 1995 Sep; 34(9):1140-6. PubMed ID: 7559307
[TBL] [Abstract][Full Text] [Related]
3. Meta-analysis: treatment of attention-deficit/hyperactivity disorder in children with comorbid tic disorders.
Bloch MH; Panza KE; Landeros-Weisenberger A; Leckman JF
J Am Acad Child Adolesc Psychiatry; 2009 Sep; 48(9):884-893. PubMed ID: 19625978
[TBL] [Abstract][Full Text] [Related]
4. Tourette Syndrome and comorbid ADHD: current pharmacological treatment options.
Rizzo R; Gulisano M; Calì PV; Curatolo P
Eur J Paediatr Neurol; 2013 Sep; 17(5):421-8. PubMed ID: 23473832
[TBL] [Abstract][Full Text] [Related]
5. [Tics and Gilles de la Tourette syndrome].
Tijero-Merino B; Gómez-Esteban JC; Zarranz JJ
Rev Neurol; 2009 Jan; 48 Suppl 1():S17-20. PubMed ID: 19222010
[TBL] [Abstract][Full Text] [Related]
6. Atomoxetine treatment of ADHD in children with comorbid Tourette syndrome.
Spencer TJ; Sallee FR; Gilbert DL; Dunn DW; McCracken JT; Coffey BJ; Budman CL; Ricardi RK; Leonard HL; Allen AJ; Milton DR; Feldman PD; Kelsey DK; Geller DA; Linder SL; Lewis DW; Winner PK; Kurlan RM; Mintz M
J Atten Disord; 2008 Jan; 11(4):470-81. PubMed ID: 17934184
[TBL] [Abstract][Full Text] [Related]
7. Concomitant use of atomoxetine and OROS-methylphenidate in a 10-year-old child suffering from attention-deficit/hyperactivity disorder with comorbid bipolar disorder and Tourette syndrome.
Jaworowski S; Benarroch F; Gross-Tsur V
J Child Adolesc Psychopharmacol; 2006 Jun; 16(3):365-70. PubMed ID: 16768644
[TBL] [Abstract][Full Text] [Related]
8. Contemporary assessment and pharmacotherapy of Tourette syndrome.
Scahill L; Erenberg G; Berlin CM; Budman C; Coffey BJ; Jankovic J; Kiessling L; King RA; Kurlan R; Lang A; Mink J; Murphy T; Zinner S; Walkup J;
NeuroRx; 2006 Apr; 3(2):192-206. PubMed ID: 16554257
[TBL] [Abstract][Full Text] [Related]
9. Mechanism of action of agents used in attention-deficit/hyperactivity disorder.
Wilens TE
J Clin Psychiatry; 2006; 67 Suppl 8():32-8. PubMed ID: 16961428
[TBL] [Abstract][Full Text] [Related]
10. Tics and Tourette syndrome.
Shaw ZA; Coffey BJ
Psychiatr Clin North Am; 2014 Sep; 37(3):269-86. PubMed ID: 25150562
[TBL] [Abstract][Full Text] [Related]
11. Aripiprazole in children with Tourette's disorder and co-morbid attention-deficit/hyperactivity disorder: a 12-week, open-label, preliminary study.
Masi G; Gagliano A; Siracusano R; Berloffa S; Calarese T; Ilardo G; Pfanner C; Magazù A; Cedro C
J Child Adolesc Psychopharmacol; 2012 Apr; 22(2):120-5. PubMed ID: 22375853
[TBL] [Abstract][Full Text] [Related]
12. Pharmacological treatment of tic disorders and Tourette Syndrome.
Roessner V; Schoenefeld K; Buse J; Bender S; Ehrlich S; Münchau A
Neuropharmacology; 2013 May; 68():143-9. PubMed ID: 22728760
[TBL] [Abstract][Full Text] [Related]
13. The relationship between tourette syndrome, attention deficit hyperactivity disorder, and stimulant medication: a critical review.
Erenberg G
Semin Pediatr Neurol; 2005 Dec; 12(4):217-21. PubMed ID: 16780292
[TBL] [Abstract][Full Text] [Related]
14. Current pharmacotherapeutic approaches for the treatment of Tourette syndrome.
Egolf A; Coffey BJ
Drugs Today (Barc); 2014 Feb; 50(2):159-79. PubMed ID: 24619591
[TBL] [Abstract][Full Text] [Related]
15. Tourette syndrome and other tic disorders of childhood.
Tamara P
Handb Clin Neurol; 2013; 112():853-6. PubMed ID: 23622293
[TBL] [Abstract][Full Text] [Related]
16. Quetiapine in treatment-resistant obsessive-compulsive disorder.
Cohen LS
J Am Acad Child Adolesc Psychiatry; 2003 Jun; 42(6):623-4. PubMed ID: 12921466
[No Abstract] [Full Text] [Related]
17. [Comorbid disorders associated with tics].
Fernández-Alvarez E
Rev Neurol; 2002 Feb; 34 Suppl 1():S122-9. PubMed ID: 12447802
[TBL] [Abstract][Full Text] [Related]
18. Association of cortical disinhibition with tic, ADHD, and OCD severity in Tourette syndrome.
Gilbert DL; Bansal AS; Sethuraman G; Sallee FR; Zhang J; Lipps T; Wassermann EM
Mov Disord; 2004 Apr; 19(4):416-25. PubMed ID: 15077239
[TBL] [Abstract][Full Text] [Related]
19. Advances in the treatment of attention-deficit/hyperactivity disorder: a guide for pediatric neurologists.
Wigal SB; Chae S; Patel A; Steinberg-Epstein R
Semin Pediatr Neurol; 2010 Dec; 17(4):230-6. PubMed ID: 21183129
[TBL] [Abstract][Full Text] [Related]
20. Clinical pharmacology of comorbid attention deficit hyperactivity disorder in Tourette syndrome.
Rizzo R; Gulisano M
Int Rev Neurobiol; 2013; 112():415-44. PubMed ID: 24295629
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
